Independent Journalism · Est. 2026
ACUMEN
World
National
Technology
Culture
Economy
Newsletter
For YouWorldNationalTechnologyCultureEconomyNewsletter
ACUMEN

Context-first journalism for a world overwhelmed by noise.

Get the App

Download for Android

Coverage

  • World
  • National
  • Technology
  • Economy
  • Culture
  • Newsletter

Company

  • About
  • Press
  • Ethics Policy
© 2026 Acumen News. All rights reserved.
PrivacyTermsCookies
Independent Journalism · Est. 2026
ACUMEN
World
National
Technology
Culture
Economy
Newsletter
For YouWorldNationalTechnologyCultureEconomyNewsletter
ACUMEN

Context-first journalism for a world overwhelmed by noise.

Get the App

Download for Android

Coverage

  • World
  • National
  • Technology
  • Economy
  • Culture
  • Newsletter

Company

  • About
  • Press
  • Ethics Policy
© 2026 Acumen News. All rights reserved.
PrivacyTermsCookies
Independent Journalism · Est. 2026
ACUMEN
World
National
Technology
Culture
Economy
Newsletter
For YouWorldNationalTechnologyCultureEconomyNewsletter
All Stories

Technology

1337 articles · sorted by newest first

AllAI & SocietyBig Tech & MarketsScience & SpaceCyber & Privacy

Latest in Technology

Latest in Technology
20 results
Technology 6/14/2026

Las Vegas startup bets AI can transform heart disease detection

Las Vegas-based startup Medaica is set to disrupt cardiovascular care with the imminent direct-to-consumer launch of its AI-powered home heart exam kit, aiming to make early heart disease detection more accessible and affordable. The kit, featuring an FDA-cleared digital stethoscope and an AI-assisted cardiologist review, represents a significant push into proactive, at-home health screening at a time when cardiovascular disease remains the leading cause of death globally. This move could fundamentally shift how millions approach heart health, moving diagnostics out of the clinic and into patients' hands.

Editorial Team1 min
Las Vegas startup bets AI can transform heart disease detection
Technology 6/14/2026

Huawei Unveils HarmonyOS 7: AI Agents Reshape the OS as Xiaoyi Becomes the System's Intelligent Core - Pandaily

Huawei has officially unveiled HarmonyOS 7 at its annual Developer Conference, fundamentally transforming its proprietary operating system with a new 'Agent-native' architecture where its Xiaoyi assistant evolves into a formidable system-level AI agent. This pivot positions HarmonyOS 7 as an 'intent-driven' platform, boasting over 2,100 system capabilities and integrating thousands of third-party AI agents, directly challenging the established mobile OS giants like Apple and Google in the burgeoning AI era.

Editorial Team1 min
Huawei Unveils HarmonyOS 7: AI Agents Reshape the OS as Xiaoyi Becomes the System's Intelligent Core - Pandaily
Technology 6/14/2026

Two phones and an app: How Russians skirt Putin's digital iron curtain

Russians are increasingly adopting sophisticated, multi-device strategies to bypass the Kremlin's intensifying digital controls, including using two phones – one for state-sanctioned apps and another for encrypted foreign messengers. This comes as mobile internet shutdowns have hit major cities like Moscow since March 2026, WhatsApp was blocked nationwide in February, and Telegram has faced widespread throttling, driving citizens to increasingly convoluted technical solutions to maintain access to independent information and international communication.

Editorial Team1 min
Two phones and an app: How Russians skirt Putin's digital iron curtain
Technology 6/14/2026

OpenAI faces investigation from state attorneys general

A powerful coalition of 42 U.S. state attorneys general has launched a sweeping investigation into OpenAI, serving the artificial intelligence giant with a subpoena just days after its confidential Initial Public Offering filing. The wide-ranging probe, coordinated by the New York Attorney General's office, demands documents on everything from the company's advertising practices and handling of sensitive health data to its impact on minors and seniors. This unprecedented multi-state action signals a dramatic escalation in regulatory scrutiny for one of the world's leading AI developers, potentially redefining the landscape of responsible AI deployment.

Editorial Team1 min
OpenAI faces investigation from state attorneys general
Technology 6/14/2026

Genmab A/S: Genmab Announces Epcoritamab Monotherapy and Epcoritamab-Based Combination Regimens Demonstrate High Response Rates in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

Genmab A/S has unveiled compelling new data at the European Hematology Association (EHA) 2026 Congress, demonstrating high response rates for its bispecific antibody, epcoritamab, in elderly patients with newly diagnosed Diffuse Large B-Cell Lymphoma (DLBCL). Results from the Phase 2 EPCOREDLBCL-3 trial showed a 67% Overall Response Rate (ORR) and a 58% Complete Response (CR) rate with epcoritamab monotherapy in this particularly vulnerable patient group. Concurrently, data from the Phase 1b/2 EPCORE NHL-2 trial highlighted an impressive 93% ORR and 86% CR rate for epcoritamab in combination with R-mini-CHOP, signalling a potential paradigm shift for first-line treatment in a population often unable to tolerate intensive standard chemotherapy.

Editorial Team1 min
Genmab A/S: Genmab Announces Epcoritamab Monotherapy and Epcoritamab-Based Combination Regimens Demonstrate High Response Rates in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)
Technology 6/14/2026

GLP-1 Initiation Associated With Increase in Hypotensive Events in Patients With Hypertension - HCPLive

A new study presented at the Endocrine Society (ENDO) Annual Meeting 2026 reveals that initiating GLP-1 receptor agonist therapy in patients with pre-existing hypertension is associated with a statistically significant increase in hypotensive events, including fainting, dizziness, and falls. This finding from Northwestern Medicine researchers challenges the widely held view of GLP-1s as uniformly beneficial for cardiovascular health, introducing a critical safety nuance for a large, vulnerable patient population already managing high blood pressure with multiple medications.

Editorial Team1 min
GLP-1 Initiation Associated With Increase in Hypotensive Events in Patients With Hypertension - HCPLive
Technology 6/13/2026

SpaceX Creates History, Becomes 6th Most Valuable US-Listed Company At $161 Share Price

SpaceX, the aerospace and AI powerhouse led by Elon Musk, roared onto the Nasdaq exchange on June 12, 2026, under the ticker SPCX, achieving a staggering $2.1 trillion market capitalization on its debut. Closing its first day at $160.95 per share after pricing at $135, the historic Initial Public Offering officially crowned Musk as the world's first trillionaire and positioned SpaceX as the sixth most valuable US-listed company. This unprecedented market entry shatters previous IPO records and signals a new era for the commercial space and artificial intelligence sectors.

Editorial Team1 min
SpaceX Creates History, Becomes 6th Most Valuable US-Listed Company At $161 Share Price
Technology 6/13/2026

Anthropic is pulling its two newest AI models after a U.S. government directive

Anthropic, the prominent AI developer, has abruptly disabled its two newest and most advanced artificial intelligence models, Claude Fable 5 and Mythos 5, for all global users following an unprecedented export control directive from the U.S. government. Issued by Commerce Secretary Howard Lutnick on Friday, June 12, 2026, just three days after their launch, the order cites unspecified national security concerns, marking a significant escalation in Washington's bid to control frontier AI technologies and raising immediate questions about future AI deployment.

Editorial Team1 min
Anthropic is pulling its two newest AI models after a U.S. government directive
Technology 6/13/2026

Meta made 'mistakes' in AI workforce shift, says CEO Mark Zuckerberg

Meta CEO Mark Zuckerberg has publicly admitted the company 'made mistakes' in its sweeping, multi-billion-dollar push to reorient its workforce around Artificial Intelligence, following a May restructuring that saw 8,000 employees laid off and another 7,000 reassigned to new AI initiatives. The admission, revealed in an internal memo, signals the immense operational challenges even tech giants face in the frantic race to dominate AI.

Editorial Team1 min
Meta made 'mistakes' in AI workforce shift, says CEO Mark Zuckerberg
Technology 6/13/2026

FDA approves new adjuvant treatment option for ccRCC patients with recurrence risk

The U.S. Food and Drug Administration (FDA) has delivered a significant win for kidney cancer patients, approving Merck's immunotherapy Keytruda (pembrolizumab) in combination with its HIF-2α inhibitor Welireg (belzutifan) as an adjuvant treatment for adults with clear cell renal cell carcinoma (ccRCC) at intermediate-high or high risk of recurrence following surgical removal of the kidney. This landmark approval marks the first time a PD-1 and HIF-2α inhibitor combination has been greenlit, offering a crucial new post-surgery option to reduce the chance of cancer returning.

Editorial Team1 min
FDA approves new adjuvant treatment option for ccRCC patients with recurrence risk
Technology 6/13/2026

Zuckerberg says Meta made 'mistakes' in AI workforce shift - CNA

Mark Zuckerberg, CEO of Meta, has publicly admitted that the company made 'mistakes' in its aggressive AI-driven workforce transformation, following a May restructuring that saw 8,000 employees laid off and another 7,000 reassigned to new AI initiatives. The admission, made in an internal memo, arrives amidst widespread employee discontent, particularly within the newly formed Applied AI Engineering unit, where some 'force-transferred' staff liken their experience to a 'gulag' of menial tasks. This significant overhaul underscores Meta's relentless pursuit of artificial intelligence dominance, even as it navigates internal upheaval.

Editorial Team1 min
Zuckerberg says Meta made 'mistakes' in AI workforce shift - CNA
Technology 6/13/2026

Google unveils DiffusionGemma, an AI model that breaks free of left-to-right processing

Google DeepMind has officially unveiled DiffusionGemma, an experimental open AI model that radically departs from conventional large language models' (LLMs) sequential, left-to-right processing. Launched on June 10, 2026, this innovative 26-billion-parameter model leverages text diffusion techniques, similar to those used in image generation, to create entire blocks of text simultaneously, delivering up to four times faster inference speeds on dedicated GPUs. This architectural shift targets a critical bottleneck in local, single-user AI applications, where traditional models often underutilize hardware resources.

Editorial Team1 min
Google unveils DiffusionGemma, an AI model that breaks free of left-to-right processing
Technology 6/13/2026

SpaceX, Anthropic, and OpenAI’s hot IPO summer

SpaceX's monumental public debut on June 12, which shattered records to become the largest Initial Public Offering in history with a valuation exceeding $2 trillion, signals a seismic shift in the technology investment landscape. This unprecedented listing, coupled with confidential IPO filings from AI powerhouses Anthropic and OpenAI, has officially ushered in the 'MANGOS' era, eclipsing the long-reigning FAANG cohort and reorienting Wall Street's focus towards artificial intelligence and space infrastructure.

Editorial Team1 min
SpaceX, Anthropic, and OpenAI’s hot IPO summer
Technology 6/13/2026

Samsung HBM4E, Kioxia And HPE Storage, And Peak:AIO Metadata Server

The relentless race for AI supremacy has ignited a trifecta of groundbreaking advancements in memory and storage, signaling a major leap for data-intensive computing. Samsung has begun shipping industry-first 12-layer HBM4E samples, promising a significant boost for next-generation AI workloads, while Kioxia is deepening its partnership with HPE to extend high-performance storage from terrestrial data centers to ambitious lunar exploration. Concurrently, Peak:AIO and Los Alamos National Laboratory have unveiled 'Lattice,' an open-source pNFS metadata server designed to shatter a critical bottleneck plaguing large-scale AI and High-Performance Computing (HPC) systems.

Editorial Team1 min
Samsung HBM4E, Kioxia And HPE Storage, And Peak:AIO Metadata Server
Technology 6/13/2026

World's first trillionaire: Elon Musk's net worth cross $1 trillion after SpaceX's stock market debut

Elon Musk has officially become the world's first trillionaire, a historic milestone propelled by SpaceX's record-shattering debut on the Nasdaq on June 12, 2026. The aerospace and AI titan saw its shares surge by nearly 20% on the first day of trading, rocketing the company's market capitalization past $2 trillion and anchoring Musk's personal fortune at an estimated $1.1 trillion.

Editorial Team1 min
World's first trillionaire: Elon Musk's net worth cross $1 trillion after SpaceX's stock market debut
Technology 6/13/2026

Facebook down globally: Lakhs of users report issues with app, feed and login

Meta's flagship platforms—Facebook, Instagram, and Messenger—suffered a widespread global outage on Friday, June 12, 2026, locking out millions of users and disrupting businesses worldwide. The sudden disruption, starting around 9:30 AM ET, saw users unable to log in, refresh feeds, or send messages, raising urgent questions about the resilience of critical digital infrastructure. While services largely began to restore within hours, Instagram experienced a more prolonged recovery period, leaving a significant segment of the digital economy in limbo.

Editorial Team1 min
Facebook down globally: Lakhs of users report issues with app, feed and login
Technology 6/12/2026

Why Nokia is betting on AI-powered networks

Nokia, the venerable Finnish telecom giant, is making a forceful comeback by pivoting sharply into AI-driven network infrastructure and next-generation 6G technology, underscored by a major new 'agentic AI framework' for its Network Services Platform announced just this week. This strategic reorientation has already sent its stock surging over 140% year-to-date in 2026, redefining its market perception from a legacy equipment maker to a critical player in the global AI supercycle.

Editorial Team1 min
Why Nokia is betting on AI-powered networks
Technology 6/12/2026

Encapsulation Research Advances Mission-Critical Materials

Researchers at the Johns Hopkins Applied Physics Laboratory (APL) have achieved a breakthrough in encapsulation, a technique that precisely controls the activation of reactive chemicals encased in microscopic shells. This innovation is dramatically enhancing the performance of mission-critical materials, yielding underwater adhesives that are over 500% stronger and intaglio printing inks that dry 50% faster, critical for secure document production. The advancement, led by APL scientists like Reid Messersmith, Leslie Hamilton, and Allison Moyer, promises to redefine material reliability in challenging environments.

Editorial Team1 min
Encapsulation Research Advances Mission-Critical Materials
Technology 6/12/2026

International experts issue new MRI-based prostate cancer screening guidance - Radiology Business

International experts have just unveiled a landmark new consensus, the Prostate Imaging Standards for Screening Magnetic Resonance Imaging (PRISM) recommendations, poised to redefine prostate cancer screening globally. Published on June 11, 2026, in JAMA Oncology, this guidance, spearheaded by Imperial College London's Dr. Nikhil Mayor, champions a streamlined, faster, and more cost-effective biparametric MRI (bpMRI) approach, aiming to improve early detection while reducing the harms associated with traditional screening.

Editorial Team1 min
International experts issue new MRI-based prostate cancer screening guidance - Radiology Business
Technology 6/12/2026

Ono Pharma submits supplemental application in Japan to expand the Use of Opdivo to treat unresectable anaplastic thyroid cancer

Ono Pharmaceutical has submitted a critical supplemental application in Japan to broaden the use of its blockbuster immunotherapy, Opdivo (nivolumab), specifically for treating unresectable anaplastic thyroid cancer (ATC). This move, based on compelling Phase 2 data from the investigator-initiated NAVIGATION study, which paired Opdivo with Eisai's Lenvima, signals a potential breakthrough against one of the most aggressive and rapidly fatal forms of cancer, offering a new lifeline where current options are severely limited. The combination therapy achieved a 47.6% objective response rate, meeting its primary endpoint with a manageable safety profile.

Editorial Team1 min
Ono Pharma submits supplemental application in Japan to expand the Use of Opdivo to treat unresectable anaplastic thyroid cancer
‹ Prev1…5051525354…67Next ›

Page 52 of 67 · 1337 articles

ACUMEN

Context-first journalism for a world overwhelmed by noise.

Get the App

Download for Android

Coverage

  • World
  • National
  • Technology
  • Economy
  • Culture
  • Newsletter

Company

  • About
  • Press
  • Ethics Policy
© 2026 Acumen News. All rights reserved.
PrivacyTermsCookies